ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $35,000 | +34.6% | 50,400 | 0.0% | 0.00% | – |
Q3 2020 | $26,000 | -29.7% | 50,400 | 0.0% | 0.00% | – |
Q2 2020 | $37,000 | -21.3% | 50,400 | 0.0% | 0.00% | – |
Q1 2020 | $47,000 | -54.4% | 50,400 | 0.0% | 0.00% | – |
Q4 2019 | $103,000 | -39.4% | 50,400 | -14.7% | 0.00% | – |
Q3 2019 | $170,000 | -62.5% | 59,107 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $453,000 | -40.2% | 59,107 | +3.7% | 0.00% | 0.0% |
Q1 2019 | $758,000 | -41.5% | 57,007 | -31.4% | 0.00% | -50.0% |
Q4 2018 | $1,296,000 | -26.2% | 83,157 | -7.0% | 0.00% | 0.0% |
Q3 2018 | $1,756,000 | -14.2% | 89,380 | +25.3% | 0.00% | -33.3% |
Q2 2018 | $2,047,000 | +14.9% | 71,311 | -5.4% | 0.00% | 0.0% |
Q1 2018 | $1,782,000 | +21.4% | 75,364 | +10.1% | 0.00% | +50.0% |
Q4 2017 | $1,468,000 | -5.4% | 68,452 | +4.4% | 0.00% | 0.0% |
Q3 2017 | $1,551,000 | +22.2% | 65,571 | +1.8% | 0.00% | 0.0% |
Q2 2017 | $1,269,000 | -3.1% | 64,400 | +3.2% | 0.00% | 0.0% |
Q1 2017 | $1,310,000 | +1.6% | 62,400 | -9.0% | 0.00% | 0.0% |
Q4 2016 | $1,290,000 | -30.2% | 68,600 | -22.5% | 0.00% | -33.3% |
Q3 2016 | $1,848,000 | -18.5% | 88,500 | -0.4% | 0.00% | -25.0% |
Q2 2016 | $2,267,000 | -2.2% | 88,900 | +1.5% | 0.00% | 0.0% |
Q1 2016 | $2,317,000 | -29.0% | 87,600 | +14.8% | 0.00% | -20.0% |
Q4 2015 | $3,264,000 | +54.3% | 76,300 | -4.4% | 0.01% | +25.0% |
Q3 2015 | $2,115,000 | -20.5% | 79,800 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $2,660,000 | -20.2% | 79,800 | +4.6% | 0.00% | -20.0% |
Q1 2015 | $3,334,000 | 0.0% | 76,300 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $3,334,000 | +4.6% | 76,300 | -18.9% | 0.01% | +25.0% |
Q3 2014 | $3,188,000 | -1.4% | 94,100 | -1.9% | 0.00% | 0.0% |
Q2 2014 | $3,233,000 | -7.0% | 95,900 | +1.9% | 0.00% | -20.0% |
Q1 2014 | $3,477,000 | +47.0% | 94,100 | +19.9% | 0.01% | +66.7% |
Q4 2013 | $2,366,000 | -11.7% | 78,500 | +0.4% | 0.00% | -40.0% |
Q3 2013 | $2,681,000 | +2.7% | 78,202 | -1.1% | 0.01% | 0.0% |
Q2 2013 | $2,610,000 | – | 79,102 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |